Hofheinz, R., Gencer, D., & Schneeweiss, A. (2015). Mapisal versus urea cream as prophylaxis for capecitabine-associated hand-foot syndrome: A randomized phase III trial of the AIO Quality of Life Working Group. Journal of clinical oncology, 33(22), . https://doi.org/10.1200/JCO.2014.60.4587
Chicago-Zitierstil (17. Ausg.)Hofheinz, Ralf-Dieter, Deniz Gencer, und Andreas Schneeweiss. "Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-associated Hand-foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group." Journal of Clinical Oncology 33, no. 22 (2015). https://doi.org/10.1200/JCO.2014.60.4587.
MLA-Zitierstil (9. Ausg.)Hofheinz, Ralf-Dieter, et al. "Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-associated Hand-foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group." Journal of Clinical Oncology, vol. 33, no. 22, 2015, https://doi.org/10.1200/JCO.2014.60.4587.